# Nuo Therapeutics, Inc.: filings

AURX · OTC · CIK 1091596 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aurx.md) · [Financials](/companies/aurx/financials.md) · [Filings](/companies/aurx/filings.md) · [Insiders](/companies/aurx/insiders.md)

## Reports and events: 270 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 298, 8-K 134, 424B3 75, 10-Q 48, POS AM 25, EFFECT 24, CORRESP 19, 3 17, 10-K 16, D 16, DEF 14A 14, UPLOAD 14, 4/A 12, SC 13D/A 11, 8-K/A 10, 5 9, PRE 14A 9, SC 13G/A 9, S-1/A 8, 10-Q/A 7, NT 10-K 7, NT 10-Q 7, S-1 7, S-3/A 7, SC 13D 7, 10-K/A 6, SC 13G 6, 3/A 4, 424B5 4, S-3 4, S-8 4, POS EX 3, DEF 14C 2, DEFA14A 2, RW 2, S-8 POS 2, SCHEDULE 13D/A 2, 25-NSE 1, 8-A12G 1, PRE 14C 1, SC 14D9 1, SCHEDULE 13G/A 1, SC TO-T 1, SC TO-T/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:57 ET | [8-K](/filings/0001437749-26-032242.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-032242 |
| 2026-08-17 | 11:55 ET | [8-K](/filings/0001437749-26-028109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-028109 |
| 2026-08-14 | 21:10 ET | [10-Q](/filings/0001437749-26-028053.md) | Quarterly report, period 2026-06-30 | 0001437749-26-028053 |
| 2026-06-03 | 15:04 ET | [SCHEDULE 13D/A](/filings/0001674752-26-000002.md) | Ownership report, active investor, amended | 0001674752-26-000002 |
| 2026-06-03 | 21:41 ET | [8-K](/filings/0001437749-26-019199.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-019199 |
| 2026-05-14 | 21:11 ET | [8-K](/filings/0001437749-26-017116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017116 |
| 2026-05-14 | 21:00 ET | [10-Q](/filings/0001437749-26-017104.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017104 |
| 2026-03-30 | 21:38 ET | [10-K](/filings/0001437749-26-010360.md) | Annual report, period 2025-12-31 | 0001437749-26-010360 |
| 2026-01-26 | 23:05 ET | [SCHEDULE 13D/A](/filings/0001437749-26-002120.md) | Ownership report, active investor, amended | 0001437749-26-002120 |
| 2026-01-26 | 21:25 ET | [8-K](/filings/0001437749-26-002078.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-002078 |
| 2025-12-17 | 16:09 ET | [8-K](/filings/0001437749-25-038091.md) | 5.07 Shareholder vote results | 0001437749-25-038091 |
| 2025-10-30 | 20:31 ET | [10-Q](/filings/0001437749-25-032437.md) | Quarterly report, period 2025-09-30 | 0001437749-25-032437 |
| 2025-10-30 | 17:10 ET | [DEF 14A](/filings/0001437749-25-032357.md) | Proxy statement, period 2025-12-16 | 0001437749-25-032357 |
| 2025-10-10 | 12:30 ET | [8-K](/filings/0001437749-25-030813.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001437749-25-030813 |
| 2025-07-31 | 13:19 ET | [10-Q](/filings/0001437749-25-024043.md) | Quarterly report, period 2025-06-30 | 0001437749-25-024043 |
| 2025-05-15 | 20:32 ET | [8-K](/filings/0001437749-25-017214.md) | 1.01 Entry into a material agreement | 0001437749-25-017214 |
| 2025-04-30 | 13:31 ET | [10-Q](/filings/0001437749-25-013653.md) | Quarterly report, period 2025-03-31 | 0001437749-25-013653 |
| 2025-04-01 | 14:28 ET | [10-K](/filings/0001437749-25-010379.md) | Annual report, period 2024-12-31 | 0001437749-25-010379 |
| 2024-11-12 | 13:00 ET | [10-Q](/filings/0001437749-24-034325.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034325 |
| 2024-09-19 | 20:56 ET | [8-K](/filings/0001437749-24-029602.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-029602 |
| 2024-08-12 | 12:31 ET | [10-Q](/filings/0001437749-24-025952.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025952 |
| 2024-06-27 | 20:15 ET | [8-K](/filings/0001437749-24-021407.md) | 8.01 Other events | 0001437749-24-021407 |
| 2024-06-11 | 20:26 ET | [8-K](/filings/0001437749-24-019961.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-24-019961 |
| 2024-05-21 | 12:30 ET | [8-K](/filings/0001437749-24-017754.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-017754 |
| 2024-05-15 | 21:00 ET | [10-Q](/filings/0001437749-24-017125.md) | Quarterly report, period 2024-03-31 | 0001437749-24-017125 |
| 2024-04-19 | 21:23 ET | [10-K](/filings/0001437749-24-012587.md) | Annual report, period 2023-12-31 | 0001437749-24-012587 |
| 2024-04-16 | 21:26 ET | [8-K](/filings/0001437749-24-012214.md) | 7.01 Regulation FD disclosure | 0001437749-24-012214 |
| 2023-12-20 | 19:18 ET | [SC 13D/A](/filings/0001437749-23-034986.md) | Ownership report, active investor, amended | 0001437749-23-034986 |
| 2023-12-20 | 14:02 ET | [8-K](/filings/0001437749-23-034949.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-23-034949 |
| 2023-11-20 | 21:30 ET | [10-Q](/filings/0001437749-23-032632.md) | Quarterly report, period 2023-09-30 | 0001437749-23-032632 |
| 2023-08-14 | 20:30 ET | [10-Q](/filings/0001437749-23-023710.md) | Quarterly report, period 2023-06-30 | 0001437749-23-023710 |
| 2023-08-03 | 20:15 ET | [8-K](/filings/0001437749-23-021942.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-23-021942 |
| 2023-05-15 | 20:56 ET | [10-Q](/filings/0001437749-23-014639.md) | Quarterly report, period 2023-03-31 | 0001437749-23-014639 |
| 2023-04-18 | 01:32 ET | [10-K/A](/filings/0001437749-23-010489.md) | Annual report, amended, period 2022-12-31 | 0001437749-23-010489 |
| 2023-04-17 | 22:08 ET | [10-K](/filings/0001437749-23-010351.md) | Annual report, period 2022-12-31 | 0001437749-23-010351 |
| 2022-12-05 | 21:30 ET | [8-K](/filings/0001437749-22-028414.md) | 5.07 Shareholder vote results | 0001437749-22-028414 |
| 2022-11-04 | 21:25 ET | [10-Q](/filings/0001437749-22-026082.md) | Quarterly report, period 2022-09-30 | 0001437749-22-026082 |
| 2022-11-04 | 21:19 ET | [10-Q](/filings/0001437749-22-026078.md) | Quarterly report, period 2021-09-30 | 0001437749-22-026078 |
| 2022-10-20 | 12:33 ET | [DEF 14A](/filings/0001437749-22-024416.md) | Proxy statement, period 2022-12-02 | 0001437749-22-024416 |
| 2022-09-30 | 20:01 ET | [8-K](/filings/0001437749-22-023298.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001437749-22-023298 |
| 2022-08-30 | 12:15 ET | [8-K](/filings/0001437749-22-021470.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-021470 |
| 2022-08-10 | 17:28 ET | [10-Q/A](/filings/0001437749-22-019741.md) | Quarterly report, amended, period 2022-06-30 | 0001437749-22-019741 |
| 2022-08-08 | 20:48 ET | [10-Q](/filings/0001437749-22-019392.md) | Quarterly report, period 2022-06-30 | 0001437749-22-019392 |
| 2022-07-05 | 12:02 ET | [SC 13D/A](/filings/0001437749-22-016504.md) | Ownership report, active investor, amended | 0001437749-22-016504 |
| 2022-07-05 | 12:01 ET | [SC 13D/A](/filings/0001437749-22-016503.md) | Ownership report, active investor, amended | 0001437749-22-016503 |
| 2022-07-05 | 12:01 ET | [SC 13D](/filings/0001437749-22-016502.md) | Ownership report, active investor | 0001437749-22-016502 |
| 2022-06-28 | 12:30 ET | [8-K](/filings/0001437749-22-016051.md) | 8.01 Other events | 0001437749-22-016051 |
| 2022-05-16 | 20:38 ET | [10-Q](/filings/0001437749-22-012650.md) | Quarterly report, period 2022-03-31 | 0001437749-22-012650 |
| 2022-05-02 | 12:30 ET | [8-K](/filings/0001437749-22-010347.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-22-010347 |
| 2022-04-15 | 21:14 ET | [10-K](/filings/0001437749-22-009050.md) | Annual report, period 2021-12-31 | 0001437749-22-009050 |

Page 1 of 6. [Older](/companies/aurx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.